| 1 |
35078513 | Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional study. | 2022 Jan 25 |
1 |
| 2 |
35084711 | Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer. | 2022 Apr |
2 |
| 3 |
35222283 | Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma. | 2022 |
1 |
| 4 |
35396334 | The hexosamine pathway and coat complex II promote malignant adaptation to nutrient scarcity. | 2022 Jul |
2 |
| 5 |
33037887 | Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes. | 2021 Feb |
1 |
| 6 |
33342691 | Rapid and homogeneous electrochemical detection by fabricating a high affinity bispecific antibody-enzyme complex using two Catcher/Tag systems. | 2021 Mar 1 |
2 |
| 7 |
33513399 | High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma. | 2021 Apr 15 |
3 |
| 8 |
33737524 | Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate. | 2021 Mar 18 |
1 |
| 9 |
34155348 | PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs. | 2021 Jul |
1 |
| 10 |
34299635 | Novel Perbutyrylated Glucose Derivatives of (-)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking. | 2021 Jul 19 |
1 |
| 11 |
34367462 | Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance. | 2021 |
1 |
| 12 |
34402100 | Fatty acid synthase mediates high glucose-induced EGFR activation in oral dysplastic keratinocytes. | 2021 Oct |
4 |
| 13 |
34873433 | MicroRNA-133b Inhibition Restores EGFR Expression and Accelerates Diabetes-Impaired Wound Healing. | 2021 |
1 |
| 14 |
34957737 | Relationship between 18F-FDG PET/CT radiometabolic markers and EGFR mutation, positive ALK Expression in patients with non-small cell lung cancer. | 2021 Dec |
1 |
| 15 |
32115801 | Saccharide analog, 2-deoxy-d-glucose enhances 4-1BB-mediated antitumor immunity via PD-L1 deglycosylation. | 2020 Jul |
1 |
| 16 |
32160892 | Association between serum HER2/ErbB2 levels and coronary artery disease: a case-control study. | 2020 Mar 11 |
1 |
| 17 |
32802113 | In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway. | 2020 |
1 |
| 18 |
32831963 | Relationship of EGFR Mutation to Glucose Metabolic Activity and Asphericity of Metabolic Tumor Volume in Lung Adenocarcinoma. | 2020 Aug |
1 |
| 19 |
32969198 | LncRNA ARAP1-AS2 promotes high glucose-induced human proximal tubular cell injury via persistent transactivation of the EGFR by interacting with ARAP1. | 2020 Nov |
2 |
| 20 |
30320488 | CD147-mediated glucose metabolic regulation contributes to the predictive role of 18 F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC. | 2019 Feb |
2 |
| 21 |
30542713 | Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways. | 2019 Jan |
2 |
| 22 |
30794834 | Variations in glucose/C-peptide ratio in patients with type 2 diabetes associated with renal function. | 2019 Apr |
2 |
| 23 |
31114359 | SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK/mTOR signaling. | 2019 |
2 |
| 24 |
31126985 | Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival. | 2019 Jul 5 |
1 |
| 25 |
31199048 | SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. | 2019 Sep |
6 |
| 26 |
31222577 | Recognition of early and late stages of bladder cancer using metabolites and machine learning. | 2019 Jun 20 |
1 |
| 27 |
31532771 | EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling. | 2019 |
1 |
| 28 |
31668020 | Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes. | 2019 Dec |
1 |
| 29 |
29361535 | Regulation of profibrotic responses by ADAM17 activation in high glucose requires its C-terminus and FAK. | 2018 Feb 20 |
1 |
| 30 |
29702094 | ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer. | 2018 Jun 12 |
3 |
| 31 |
30132034 | The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure. | 2018 Oct |
1 |
| 32 |
30220973 | Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells. | 2018 Aug 24 |
3 |
| 33 |
28422979 | Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma. | 2017 |
3 |
| 34 |
28610620 | Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: a cross-sectional study. | 2017 Jun 13 |
1 |
| 35 |
28670141 | High glucose levels promote the proliferation of breast cancer cells through GTPases. | 2017 |
2 |
| 36 |
29035366 | Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. | 2017 Nov |
2 |
| 37 |
26830074 | Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study). | 2016 Mar |
1 |
| 38 |
26973211 | Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib. | 2016 Apr |
2 |
| 39 |
27178822 | 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells. | 2016 |
1 |
| 40 |
25726335 | Marker of lipid peroxidation related to diabetic nephropathy in Indonesian type 2 diabetes mellitus patients. | 2015 Apr |
1 |
| 41 |
26114862 | The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes. | 2015 |
3 |
| 42 |
26268398 | The relationship between mean arterial pressure and decreased glomerular filtration rate in rural areas of Northeast China. | 2015 Aug 13 |
2 |
| 43 |
26320552 | Nuclear EGFR renders cells radio-resistant by binding mRNA species and triggering a metabolic switch to increase lactate production. | 2015 Sep |
1 |
| 44 |
24436478 | Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. | 2014 Apr |
1 |
| 45 |
24928511 | Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma. | 2014 Jul 25 |
2 |
| 46 |
25047354 | Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%. | 2014 |
1 |
| 47 |
25360521 | Fluctuation between fasting and 2-H postload glucose state is associated with glomerular hyperfiltration in newly diagnosed diabetes patients with HbA1c < 7%. | 2014 |
1 |
| 48 |
23370527 | Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells. | 2013 May |
2 |
| 49 |
23531874 | A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal. | 2013 Mar |
1 |
| 50 |
23533381 | Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells. | 2013 |
4 |